SCHEMBL7657201

SCHEMBL7657201

O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1C(=O)O)c1c[nH]c2cccc(F)c12

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.58
CYP2D6 P10635 4/20 0.58
CYP2C9 P11712 4/20 0.58
CYP3A4 P08684 1/20 0.51
EIF4A3 P38919 1/20 0.41
ALOX5 P09917 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALOX15 P16050 1/20 0.39
GHSR Q92847 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.38
CXCR3 P49682 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658565 0.90 CYP2C19 (0.55) CYP2C19CYP2D6CYP2C9CYP3A4EIF4A3
SCHEMBL7655825 0.89 CYP2C19 (0.74) CYP2C19CYP2D6CYP2C9CYP3A4GHSR
SCHEMBL7846375 0.89 CYP2C19 (0.74) CYP2C19CYP2D6CYP2C9CYP3A4GHSR
SCHEMBL7662372 0.88 CYP2C19 (0.55) CYP2C19CYP2D6CYP2C9CYP3A4EIF4A3
SCHEMBL7651473 0.88 CYP2C19 (0.54) CYP2C19CYP2D6CYP2C9CYP3A4EIF4A3
SCHEMBL4247829 0.85 CYP2C9 (0.52) CYP2C19CYP2D6CYP2C9CYP3A4KDM4E
SCHEMBL7665279 0.83 CYP2C19 (0.62) CYP2C19CYP2D6CYP2C9CYP3A4GHSR
SCHEMBL1732894 0.77 POLB (0.46) CYP2C19CYP2D6CYP2C9CYP3A4KDM4E
SCHEMBL12151872 0.77 POLB (0.46) CYP2C19CYP2D6CYP2C9CYP3A4KDM4E
SCHEMBL12151879 0.76 POLB (0.45) CYP2C19CYP2D6CYP2C9CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469006-B1 PARTICULARLY FOR TREATING HIV INFECTIONS BRISTOL-MYERS SQUIBB COMPANY 2002-10-22 US disclosed
EP-1105135-A4 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2001-12-12 EP disclosed
EP-1105135-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-06-13 EP disclosed
WO-2000076521-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-12-21 WO disclosed